Dow Up 0.51% Nasdaq Up 0.24%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
35.94 0.15(0.42%) Nov 21, 4:00PM EST
|After Hours : 35.94 0.00 (0.00%) Nov 21, 5:00PM EST
Prev Close:36.09
Open:36.70
Bid:29.70 x 400
Ask:N/A
1y Target Est:43.82
Beta:1.88
Earnings Date:Feb 11 - Feb 16 (Est.)
Day's Range:35.80 - 36.84
52wk Range:27.51 - 39.95
Volume:465,410
Avg Vol (3m):706,789
Market Cap:1.48B
P/E (ttm):65.46
EPS (ttm):0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACOR

Comparison

Symbol% ChgMkt Cap
ACORDown 0.42%1.48B
BIIB71.68B
TEVA49.07B

Key Statistics

Forward P/E (1 yr):156.26
P/S (ttm):3.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.47
Quarterly EPS Est (Dec-14) :0.06
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.71

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback